Breaking News Instant updates and real-time market news.

2020-08-10 16:18:59 SIEN Sientra $4.24 / +0.055 (+1.31%) 16:18 08/10/20 08/10 16:18 08/10/20 16:18	Sientra reports Q2 EPS (68c), consensus (43c) Reports Q2 revenue $12.4M, consensus $8.75M. Jeff Nugent, Sientra's Chairman and Chief Executive Officer, said, "While the COVID-19 pandemic has posed unprecedented challenges, we are encouraged by our performance through this stage of the recovery and our competitive position as we exited Q2. We are particularly encouraged by the durability of the demand for our OPUS(R) breast implants and tissue expanders, as well as the effectiveness of our Drive the Recovery initiatives as we continued to take share from our competitors through new account additions and further penetration of our existing customers. We also successfully transitioned our miraDry business to focus on high-margin, recurring bioTip sales and have seen utilization rates return to pre-COVID-19 levels in key geographic markets, including the United States, as we exited Q2."	10 Aug 11 Aug
SIEN Sientra $4.24 / +0.055 (+1.31%) 06/11/20 Maxim Sientra price target raised to $8 from $5 at Maxim 03/12/20 Craig-Hallum Sientra price target lowered to $9 from $14 at Craig-Hallum 03/12/20 SVB Leerink Sientra price target lowered to $6.50 from $13 at SVB Leerink 03/12/20 Maxim Sientra price target lowered to $8 from $12 at Maxim

2020-08-10 16:18:59

SIEN

Sientra

$4.24 / +0.055 (+1.31%)

16:18

08/10/20

08/10

16:18

08/10/20

16:18

Sientra reports Q2 EPS (68c), consensus (43c)

Reports Q2 revenue $12.4M, consensus $8.75M. Jeff Nugent, Sientra's Chairman and Chief Executive Officer, said, "While the COVID-19 pandemic has posed unprecedented challenges, we are encouraged by our performance through this stage of the recovery and our competitive position as we exited Q2. We are particularly encouraged by the durability of the demand for our OPUS(R) breast implants and tissue expanders, as well as the effectiveness of our Drive the Recovery initiatives as we continued to take share from our competitors through new account additions and further penetration of our existing customers. We also successfully transitioned our miraDry business to focus on high-margin, recurring bioTip sales and have seen utilization rates return to pre-COVID-19 levels in key geographic markets, including the United States, as we exited Q2."

10
Aug
11
Aug

SIEN Sientra

$4.24 / +0.055 (+1.31%)

06/11/20 Maxim: Sientra price target raised to $8 from $5 at Maxim

03/12/20 Craig-Hallum: Sientra price target lowered to $9 from $14 at Craig-Hallum

03/12/20 SVB Leerink: Sientra price target lowered to $6.50 from $13 at SVB Leerink

03/12/20 Maxim: Sientra price target lowered to $8 from $12 at Maxim

TODAY'S FREE FLY STORIES

Recommendations	Ericsson price target raised to SEK 140 from SEK 130 at Barclays » 15:16 04/14/21 04/14 15:16 04/14/21 15:16 ERIC Ericsson $13.71 / -0.275 (-1.97%) Barclays analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events Options ERIC Ericsson $13.71 / -0.275 (-1.97%) 01/27/21 Ericsson trading resumes 01/27/21 Ericsson trading halted, volatility trading pause 01/13/21 T-Mobile announces five-year agreements with Ericsson, Nokia 12/17/20 Nokia appoints Nishant Batra as chief strategy, technology officer ERIC Ericsson $13.71 / -0.275 (-1.97%) 04/08/21 Credit Suisse Ericsson price target raised to SEK 140 from SEK 125 at Credit Suisse 03/15/21 Cowen Cowen calls 'underappreciated' Ericsson 'Europe Best Idea' for 2021 03/15/21 Fly Intel: Top five analyst upgrades 03/15/21 SEB Equities Ericsson upgraded to Buy on potential U.S. capex wins at SEB ERIC Ericsson $13.71 / -0.275 (-1.97%) 01/29/21 Ericsson reports Q4 EPS SEK 2.26 vs. SEK 1.33 last year 10/21/20 Ericsson reports Q3 EPS SEK 1.61 vs. (SEK 1.89) last year ERIC Ericsson $13.71 / -0.275 (-1.97%) 01/08/21 Samsung files ITC case to block Ericsson 5G imports, Bloomberg reports 10/20/20 Swedish regulators ban Huawei, ZTE from upcoming 5G networks, Reuters reports 04/21/21 Ericsson - ERIC ERIC Ericsson $13.71 / -0.275 (-1.97%) 12:00 Today Heavy bullish option flow in Ericcson with earnings a week away 04/05/21 Ericsson call volume above normal and directionally bullish 03/25/21 Ericsson put volume heavy and directionally bearish 01/29/21 Unusually active option classes on open January 29th
Technical Analysis	NYSE market internals summary » 15:16 04/14/21 04/14 15:16 04/14/21 15:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary
Recommendations	Deutsche Post price target raised to EUR 58 from EUR 52 at Barclays » 15:15 04/14/21 04/14 15:15 04/14/21 15:15 DPSGY Deutsche Post $58.87 / +0.925 (+1.60%) Barclays analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings DPSGY Deutsche Post $58.87 / +0.925 (+1.60%) 04/12/21 UBS Deutsche Post price target raised to EUR 52.50 from EUR 48 at UBS 04/12/21 JPMorgan Deutsche Post price target raised to EUR 68.47 from EUR 55.96 at JPMorgan 03/16/21 Berenberg Deutsche Post price target raised to EUR 53 from EUR 51 at Berenberg 03/11/21 Nord/LB Deutsche Post upgraded to Buy from Hold at Nord/LB DPSGY Deutsche Post $58.87 / +0.925 (+1.60%) 04/09/21 Deutsche Post sees 2021 EBIT 'significantly above' EUR 5.6B
Recommendations	ASML price target raised to EUR 620 from EUR 525 at Barclays » 15:15 04/14/21 04/14 15:15 04/14/21 15:15 ASML ASML $629.34 / +0.025 (+0.00%) Barclays analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals ASML ASML $629.34 / +0.025 (+0.00%) 03/03/21 ASML says SMIC purchase agreement disclosure not material event ASML ASML $629.34 / +0.025 (+0.00%) 03/22/21 Cowen ASML upgraded to Outperform from Market Perform at Cowen 02/02/21 JPMorgan ASML price target raised to EUR 534 from EUR 472 at JPMorgan 02/02/21 JPMorgan ASML price target raised to $640 from $524 at JPMorgan 01/29/21 Berenberg ASML price target raised to EUR 540 from EUR 405 at Berenberg ASML ASML $629.34 / +0.025 (+0.00%) 01/20/21 ASML sees Q1 net sales EUR 3.9B-EUR 4.1B, gross margin 50%-51% 01/20/21 ASML reports Q4 EPS EUR 3.23 vs. EUR 2.54 last quarter ASML ASML $629.34 / +0.025 (+0.00%) 11/13/20 TSMC places EUV equipment orders with ASML for 2021, DigiTimes reports
Options	KE Holdings put volume heavy and directionally bearish » 15:15 04/14/21 04/14 15:15 04/14/21 15:15 BEKE KE Holdings $49.90 / -3.69 (-6.89%) Bearish flow noted in KE… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Options BEKE KE Holdings $49.90 / -3.69 (-6.89%) 03/16/21 KE Holdings rises 20.8% 03/16/21 KE Holdings rises 12.7% 03/16/21 KE Holdings rises 8.1% 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal BEKE KE Holdings $49.90 / -3.69 (-6.89%) 04/07/21 Credit Suisse KE Holdings initiated with an Outperform at Credit Suisse 03/18/21 BofA KE Holdings upgraded to Buy from Neutral at BofA 03/18/21 BofA KE Holdings upgraded to Buy from Neutral at BofA 03/11/21 Goldman Sachs KE Holdings upgraded to Buy from Neutral at Goldman Sachs BEKE KE Holdings $49.90 / -3.69 (-6.89%) 03/15/21 KE Holdings sees Q1 revenue $2.8B-$3B, consensus $2.11B 03/15/21 KE Holdings reports Q4 adjusted EPS 26c, consensus 14c 11/16/20 KE Holdings sees Q4 revenue $2.8B-$3B, consensus $2.82B 11/16/20 KE Holdings reports Q3 adjusted income per ADS 20c, consensus 17c. 19 Nov 13 Aug BEKE KE Holdings $49.90 / -3.69 (-6.89%) 04/12/21 KE Holdings put volume heavy and directionally bearish 03/24/21 KE Holdings put volume heavy and directionally bearish 01/26/21 KE Holdings put volume heavy and directionally bearish 12/07/20 KE Holdings put volume heavy and directionally bearish

Recommendations	ASM International price target raised to EUR 295 from EUR 250 at Barclays » 15:14 04/14/21 04/14 15:14 04/14/21 15:14 ASMIY ASM International $321.49 / +6.49 (+2.06%) Barclays analyst Keegan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events ASMIY ASM International $321.49 / +6.49 (+2.06%) 03/30/21 Morgan Stanley ASM International price target raised to EUR 240 from EUR 154 at Morgan Stanley 03/02/21 Deutsche Bank ASM International price target raised to EUR 250 from EUR 210 at Deutsche Bank 03/01/21 Barclays ASM International price target raised to EUR 250 from EUR 210 at Barclays 03/01/21 Credit Suisse ASM International price target raised to EUR 265 from EUR 250 at Credit Suisse 04/21/21 ASM International - ASMIY
Recommendations	Aixtron price target raised to EUR 24 from EUR 23 at Barclays » 15:14 04/14/21 04/14 15:14 04/14/21 15:14 AIXXF Aixtron $22.70 / + (+0.00%) Barclays analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AIXXF Aixtron $22.70 / + (+0.00%) 03/09/21 Berenberg Aixtron price target raised to EUR 18 from EUR 11 at Berenberg 02/26/21 Barclays Aixtron price target raised to EUR 23 from EUR 15.50 at Barclays 02/19/21 Deutsche Bank Aixtron price target raised to EUR 22 from EUR 14 at Deutsche Bank 01/14/21 Barclays Aixtron price target raised to EUR 15.50 from EUR 13 at Barclays
Recommendations	LVMH price target raised to EUR 635 from EUR 600 at RBC Capital » 15:11 04/14/21 04/14 15:11 04/14/21 15:11 LVMUY LVMH $147.85 / +6.86 (+4.87%) RBC Capital analyst Piral… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH says 'well-equipped to build upon the hoped-for recovery' 02/22/21 LVMH's Moet Hennessy takes 50% stake in Jay-Z's Armand de Brignac brand 12/31/20 Tiffany holders approve LVMH takeover, deal to close on January 7 10/29/20 LVMH, Tiffany agree to reduced takeover price of $131.50 per share LVMUY LVMH $147.85 / +6.86 (+4.87%) 15:08 Today JPMorgan LVMH price target raised to EUR 685 from EUR 625 at JPMorgan 10:46 Today Societe Generale LVMH price target raised to EUR 690 from EUR 615 at Societe Generale 04/07/21 Deutsche Bank LVMH price target raised to EUR 495 from EUR 440 at Deutsche Bank 03/30/21 UBS LVMH price target raised to EUR 640 from EUR 623 at UBS LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH reports Q1 revenue EUR 13.96B, consensus EUR 12.7B 10/15/20 LVMH reports Q3 revenue EUR 11.96B vs. EUR 13.32B last year 10/15/20 LVMH reports Q3 organic revenue down 7% LVMUY LVMH $147.85 / +6.86 (+4.87%) 02/10/21 Rihanna's Fenty fashion line put on hold, WWD reports 10/28/20 LVMH, Tiffany near deal to lower takeout price to $131.50 from $135, WSJ says 10/27/20 Tiffany seeks around $132 per share from LVMH, Bloomberg reports 10/27/20 Tiffany close to new deal price of $130-$133 per share from LVMH, CNBC says LVMUY LVMH $147.85 / +6.86 (+4.87%) 10/27/20 Fly Intel: Wall Street's top stories for Tuesday
Recommendations	Henkel price target raised to EUR 111 from EUR 104 at RBC Capital » 15:11 04/14/21 04/14 15:11 04/14/21 15:11 HENKY Henkel $25.39 / +0.1 (+0.40%) RBC Capital analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HENKY Henkel $25.39 / +0.1 (+0.40%) 15:08 Today JPMorgan Henkel price target raised to EUR 120 from EUR 115 at JPMorgan 04/06/21 Barclays Henkel price target raised to EUR 106 from EUR 94 at Barclays 04/01/21 UBS Henkel price target raised to EUR 93 from EUR 88 at UBS 03/22/21 JPMorgan Henkel price target raised to EUR 115 from EUR 100 at JPMorgan
Recommendations	Just Eat Takeaway.com price target lowered to 11,423 GBp at JPMorgan » 15:10 04/14/21 04/14 15:10 04/14/21 15:10 TKAYY Just Eat Takeaway.com $10.80 / +0.52 (+5.06%) JPMorgan analyst Marcus… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals TKAYY Just Eat Takeaway.com $10.80 / +0.52 (+5.06%) 04/07/21 Morgan Stanley Just Eat price target raised to 11,400 GBp from 11,100 GBp at Morgan Stanley 03/11/21 Barclays Just Eat Takeaway.com price target raised to 12,080 GBp from 11,990 GBp at Barclays 03/04/21 UBS Just Eat Takeaway.com price target raised to 9,800 GBp from 9,700 GBp at UBS 03/04/21 Morgan Stanley Just Eat Takeaway.com price target lowered to 11,100 GBp at Morgan Stanley TKAYY Just Eat Takeaway.com $10.80 / +0.52 (+5.06%) 03/22/21 Deliveroo targets $12B in London IPO, WSJ reports

Recommendations	VAT Group price target raised to CHF 260 from CHF 165 at JPMorgan » 15:09 04/14/21 04/14 15:09 04/14/21 15:09 VACNY VAT Group $31.05 / + (+0.00%) JPMorgan analyst Sandeep… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VACNY VAT Group $31.05 / + (+0.00%) 04/09/21 UBS VAT Group price target raised to CHF 300 from CHF 280 at UBS 01/12/21 Deutsche Bank VAT Group price target raised to CHF 225 from CHF 175 at Deutsche Bank 01/12/21 UBS VAT Group price target raised to CHF 255 from CHF 207 at UBS 11/24/20 UBS VAT Group price target raised to CHF 207 from CHF 190 at UBS
Recommendations	Tele2 price target raised to SEK 147 from SEK 145 at JPMorgan » 15:09 04/14/21 04/14 15:09 04/14/21 15:09 TLTZY Tele2 $6.96 / + (+0.00%) JPMorgan analyst Roman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLTZY Tele2 $6.96 / + (+0.00%) 03/09/21 JPMorgan Tele2 price target lowered to SEK 145 from SEK 160 at JPMorgan 02/23/21 Morgan Stanley Tele2 downgraded to Equal Weight from Overweight at Morgan Stanley 02/03/21 Barclays Tele2 price target lowered to SEK 125 from SEK 130 at Barclays 12/16/20 Deutsche Bank Tele2 price target raised to SEK 122 from SEK 117 at Deutsche Bank
Recommendations	LVMH price target raised to EUR 685 from EUR 625 at JPMorgan » 15:08 04/14/21 04/14 15:08 04/14/21 15:08 LVMUY LVMH $147.85 / +6.86 (+4.87%) JPMorgan analyst Chiara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH says 'well-equipped to build upon the hoped-for recovery' 02/22/21 LVMH's Moet Hennessy takes 50% stake in Jay-Z's Armand de Brignac brand 12/31/20 Tiffany holders approve LVMH takeover, deal to close on January 7 10/29/20 LVMH, Tiffany agree to reduced takeover price of $131.50 per share LVMUY LVMH $147.85 / +6.86 (+4.87%) 10:46 Today Societe Generale LVMH price target raised to EUR 690 from EUR 615 at Societe Generale 04/07/21 Deutsche Bank LVMH price target raised to EUR 495 from EUR 440 at Deutsche Bank 03/30/21 UBS LVMH price target raised to EUR 640 from EUR 623 at UBS 03/29/21 Morgan Stanley LVMH price target raised to EUR 625 from EUR 600 at Morgan Stanley LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH reports Q1 revenue EUR 13.96B, consensus EUR 12.7B 10/15/20 LVMH reports Q3 revenue EUR 11.96B vs. EUR 13.32B last year 10/15/20 LVMH reports Q3 organic revenue down 7% LVMUY LVMH $147.85 / +6.86 (+4.87%) 02/10/21 Rihanna's Fenty fashion line put on hold, WWD reports 10/28/20 LVMH, Tiffany near deal to lower takeout price to $131.50 from $135, WSJ says 10/27/20 Tiffany seeks around $132 per share from LVMH, Bloomberg reports 10/27/20 Tiffany close to new deal price of $130-$133 per share from LVMH, CNBC says LVMUY LVMH $147.85 / +6.86 (+4.87%) 10/27/20 Fly Intel: Wall Street's top stories for Tuesday
Recommendations	Henkel price target raised to EUR 120 from EUR 115 at JPMorgan » 15:08 04/14/21 04/14 15:08 04/14/21 15:08 HENKY Henkel $25.39 / +0.1 (+0.40%) JPMorgan analyst Celine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HENKY Henkel $25.39 / +0.1 (+0.40%) 04/06/21 Barclays Henkel price target raised to EUR 106 from EUR 94 at Barclays 04/01/21 UBS Henkel price target raised to EUR 93 from EUR 88 at UBS 03/22/21 JPMorgan Henkel price target raised to EUR 115 from EUR 100 at JPMorgan 03/19/21 Bernstein Henkel upgraded to Market Perform from Underperform at Bernstein
Recommendations	Evonik price target raised to EUR 32 from EUR 28.50 at JPMorgan » 15:07 04/14/21 04/14 15:07 04/14/21 15:07 EVKIF Evonik $35.92 / + (+0.00%) JPMorgan analyst Chetan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EVKIF Evonik $35.92 / + (+0.00%) 12/07/20 Durect to sell Lactel product line to Evonik for $15M EVKIF Evonik $35.92 / + (+0.00%) 04/07/21 Societe Generale Evonik price target raised to EUR 36 from EUR 30 at Societe Generale 03/25/21 Morgan Stanley Evonik price target raised to EUR 35 from EUR 30 at Morgan Stanley 03/09/21 DZ Bank Evonik downgraded to Hold from Buy at DZ Bank 03/08/21 Berenberg Evonik price target raised to EUR 31 from EUR 26 at Berenberg

Recommendations	Buzzi Unicem price target raised to EUR 25 from EUR 24 at JPMorgan » 15:07 04/14/21 04/14 15:07 04/14/21 15:07 BZZUY Buzzi Unicem $13.39 / + (+0.00%) JPMorgan analyst Elodie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BZZUY Buzzi Unicem $13.39 / + (+0.00%) 04:47 Today Berenberg Buzzi Unicem initiated with a Buy at Berenberg 03/30/21 Morgan Stanley Buzzi Unicem price target lowered to EUR 22.40 from EUR 22.90 at Morgan Stanley 03/29/21 Barclays Buzzi Unicem price target lowered to EUR 24 from EUR 25 at Barclays 02/26/21 JPMorgan Buzzi Unicem price target raised to EUR 24 from EUR 23 at JPMorgan
Earnings	LCI Industries sees Q1 revenue $1.0B,consensus $880.28M » 15:06 04/14/21 04/14 15:06 04/14/21 15:06 LCII LCI Industries $139.60 / +2.77 (+2.02%) LCI Industrie provided… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LCII LCI Industries $139.60 / +2.77 (+2.02%) 14:28 Today LCI Industries trading halted, news pending 02/25/21 Lippert promotes Eileen Pruitt to Deputy CHRO, Senior Legal Counsel 12/22/20 LCI Industries CEO sells 10,000 common shares LCII LCI Industries $139.60 / +2.77 (+2.02%) 09/25/20 Northcoast LCI Industries upgraded to Buy from Neutral at Northcoast 09/22/20 CJS Securities LCI Industries upgraded to Outperform from Market Perform at CJS Securities 07/15/20 CL King LCI Industries price target raised to $134 from $121 at CL King 07/06/20 Citi LCI Industries initiated with a Neutral at Citi LCII LCI Industries $139.60 / +2.77 (+2.02%) 02/09/21 LCI Industries reports Q4 EPS $1.92, consensus $1.79 11/02/20 LCI Industries reports Q3 adj. EPS $2.72, consensus $2.42 LCII LCI Industries $139.60 / +2.77 (+2.02%) 02/03/21 Fly Intel: After-Hours Movers 05/20/21 LCI Industries
Recommendations	Infosys stock reaction may reflect valuation/sentiment into report, says Stifel » 15:04 04/14/21 04/14 15:04 04/14/21 15:04 INFY Infosys $17.37 / -1.04 (-5.65%) Stifel analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options INFY Infosys $17.37 / -1.04 (-5.65%) 10:00 Today Infosys falls -4.8% 07:24 Today Infosys board recommends capital return of $2.08B, including dividend, buyback 04/08/21 Infosys announces collaboration with ArcelorMittal 03/31/21 Infosys, LivePerson announce AI-powered conversation partnership INFY Infosys $17.37 / -1.04 (-5.65%) 07:05 Today Baird Infosys price target raised to $18 from $17 at Baird 03/24/21 Bernstein Infosys upgraded to Outperform as multi-year cloud winner at Bernstein 03/23/21 Bernstein Infosys upgraded to Outperform from Market Perform at Bernstein 01/14/21 Investec Infosys downgraded to Hold from Buy at Investec INFY Infosys $17.37 / -1.04 (-5.65%) 07:23 Today Infosys sees FY22 revenue growth 12%-14% in constant currency 07:23 Today Infosys reports Q4 basic EPS 16c, consensus 16c 01/13/21 Infosys boosts FY21 revenue growth view to 4.5%-5% in constant currency 01/13/21 Infosys reports Q3 basic EPS 17c, consensus 15c INFY Infosys $17.37 / -1.04 (-5.65%) 03/03/21 Infosys wins $500M all-digital deal from Google, The Economic Times says INFY Infosys $17.37 / -1.04 (-5.65%) 08:59 Today Fly Intel: Pre-market Movers 08:30 Today Infosys - INFY INFY Infosys $17.37 / -1.04 (-5.65%) 03/04/21 Unusually active option classes on open March 4th 03/03/21 Infosysy calls see heavy early volume 10/27/20 Largest borrow rate increases among liquid names
Options	NeuroBo Pharmaceuticals options imply 29.7% move in share price post-earnings » 15:04 04/14/21 04/14 15:04 04/14/21 15:04 NRBO NeuroBo Pharmaceuticals $3.75 / + (+0.00%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options NRBO NeuroBo Pharmaceuticals $3.75 / + (+0.00%) 03/24/21 NeuroBo Pharma's contingent value rights amendment for Gemcabene approved 01/06/21 NeuroBo Pharmaceuticals acquires ANA Therapeutics NRBO NeuroBo Pharmaceuticals $3.75 / + (+0.00%) 02/01/21 H.C. Wainwright NeuroBo Pharmaceuticals price target lowered to $16 from $20 at H.C. Wainwright 06/15/20 H.C. Wainwright NeuroBo Pharmaceuticals initiated with a Buy at H.C. Wainwright NRBO NeuroBo Pharmaceuticals $3.75 / + (+0.00%) 02/03/21 new option listings on February 3rd
Hot Stocks	Capcom officially closes investigation into November 2020 ransomware attack » 15:01 04/14/21 04/14 15:01 04/14/21 15:01 CCOEY Capcom $17.01 / -0.08 (-0.47%) Capcom said that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly CCOEY Capcom $17.01 / -0.08 (-0.47%) 03/12/21 'Super Mario 3D World + Bowser's Fury' best-selling game of February, says NPD 01/20/21 EU fines Valve, Capcom, ZeniMax, others EUR7.8M for 'geo-blocking' practices 01/15/21 Activision's 'COD: Black Ops: Cold War' best-selling game of 2020, says NPD 01/06/21 Digital video game sales rose 12% y/y to $126.6B in 2020, says SuperData CCOEY Capcom $17.01 / -0.08 (-0.47%) 06/09/20 JPMorgan Capcom upgraded to Overweight from Neutral at JPMorgan CCOEY Capcom $17.01 / -0.08 (-0.47%) 02/26/21 Capcom says 'Monster Hunter Rise' will be on PC in 2022, IGN says CCOEY Capcom $17.01 / -0.08 (-0.47%) 03/23/21 Game On: Microsoft in talks to buy Discord as Sony acquires EVO 01/26/21 Game On: GameStop continues puzzling surge 11/17/20 Game On: NPD says total U.S. game industry spending continues to break records

Conference/Events	Protara Therapeutics management to meet virtually with Oppenheimer » 15:01 04/14/21 04/14 15:01 04/14/21 15:01 TARA Protara Therapeutics $16.95 / +0.27 (+1.62%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events TARA Protara Therapeutics $16.95 / +0.27 (+1.62%) 02/02/21 Protara Therapeutics reports inducement grants under Nasdaq listing rule 02/02/21 Protara Therapeutics appoints Cynthia Smith to board of directors 12/07/20 Protara Therapeutics names Jacqueline Zummo Chief Scientific Operations Officer 12/03/20 Protara Therapeutics reports inducement grants under Nasdaq listing rule TARA Protara Therapeutics $16.95 / +0.27 (+1.62%) 10/19/20 Cowen Protara Therapeutics initiated with an Outperform at Cowen 07/29/20 Fly Intel: Top five analyst initiations 07/29/20 Guggenheim Protara Therapeutics started with Buy rating, $50 target at Guggenheim 07/29/20 Guggenheim Protara Therapeutics initiated with a Buy at Guggenheim TARA Protara Therapeutics $16.95 / +0.27 (+1.62%) 03/11/21 Protara Therapeutics reports Q4 EPS (79c), consensus (54c) 11/12/20 Protara Therapeutics reports Q3 EPS ($1.26), two est. (62c) 22 Sep 04/21/21 FuboTV 04/22/21 Protara Therapeutics
Conference/Events	Paychex management to meet virtually with Oppenheimer » 14:59 04/14/21 04/14 14:59 04/14/21 14:59 PAYX Paychex $96.90 / +0.59 (+0.61%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PAYX Paychex $96.90 / +0.59 (+0.61%) 04/07/21 Paychex CEO: Net client gain was best in four years in Q3 04/06/21 Paychex sees FY22 effective tax rate 24%-25% 04/06/21 Paychex sees FY22 adjusted operating margin approximately 37% 04/06/21 Paychex sees FY22 total service revenue growth 6%-7% PAYX Paychex $96.90 / +0.59 (+0.61%) 04/07/21 Baird Paychex price target raised to $94 from $82 at Baird 04/07/21 Argus Paychex price target raised to $105 from $103 at Argus 04/07/21 BMO Capital Paychex price target raised to $96 from $93 at BMO Capital 04/07/21 Goldman Sachs Goldman boosts Paychex target, keeps Sell rating on valuation PAYX Paychex $96.90 / +0.59 (+0.61%) 04/06/21 Paychex raises FY21 adjusted EPS view to flat to down 2% from down 1%-4% 04/06/21 Paychex reports Q3 adjusted EPS 96c, consensus 92c 04/05/21 Notable companies reporting before tomorrow's open 04/05/21 Notable companies reporting before tomorrow's open PAYX Paychex $96.90 / +0.59 (+0.61%) 04/06/21 Fly Intel: Pre-market Movers 12/24/20 Fiserv, FuboTV initiations among today's top calls on Wall Street 04/21/21 Paychex
Conference/Events	Inovio management to meet virtually with Oppenheimer » 14:58 04/14/21 04/14 14:58 04/14/21 14:58 INO Inovio $8.97 / +0.235 (+2.69%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options INO Inovio $8.97 / +0.235 (+2.69%) 03/01/21 Inovio reports REVEAL 1 trial met primary, secondary endpoints 02/24/21 Qiagen, Inovio expand collaboration to develop NGS companion diagnostic 02/23/21 Inovio doses first patient in Phase 1B clinical trial for INO-4500 01/06/21 Inovio reports positive efficacy results from Phase 2 trial of VGX-3100 INO Inovio $8.97 / +0.235 (+2.69%) 03/23/21 Fly Intel: Top five analyst initiations 03/23/21 BofA Inovio initiated with a Neutral at BofA 03/02/21 Piper Sandler Piper lowers Inovio target to $7 after 'decidedly negative' update 02/11/21 Oppenheimer Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target INO Inovio $8.97 / +0.235 (+2.69%) 03/01/21 Inovio reports Q4 EPS (14c), consensus (22c) 11/09/20 Inovio reports Q3 EPS 11c, consensus (19c) 21 Jan INO Inovio $8.97 / +0.235 (+2.69%) 03/01/21 Fly Intel: After-Hours Movers 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street 02/12/21 Fly Intel: Pre-market Movers 01/21/21 Fly Intel: Pre-market Movers 04/16/21 FuboTV 05/13/21 Inovio Pharmaceuticals, Inc INO Inovio $8.97 / +0.235 (+2.69%) 03/01/21 Inovio options imply 19.7% move in share price post-earnings 02/23/21 Inovio put volume heavy and directionally bearish 02/12/21 Unusually active option classes on open February 12th 02/01/21 Inovio call volume above normal and directionally bullish
Conference/Events	Homology Medicines management to meet virtually with Oppenheimer » 14:57 04/14/21 04/14 14:57 04/14/21 14:57 FIXX Homology Medicines $7.24 / +0.07 (+0.98%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events FIXX Homology Medicines $7.24 / +0.07 (+0.98%) 08:40 Today Homology Medicines announces two presentations on phenylketonuria, MPS II 04/12/21 Homology Medicines announces promotion of Tim Kelly to COO 04/12/21 Homology Medicines announces promotion of Tim Kelly to COO 04/06/21 Homology Medicines drops 8% to $8.51 after announcing $50M stock offering FIXX Homology Medicines $7.24 / +0.07 (+0.98%) 03/01/21 Stifel Homology Medicines initiated with a Hold at Stifel 03/01/21 Oppenheimer Homology Medicines loses potential source of upside, says Oppenheimer 12/14/20 H.C. Wainwright Homology Medicines transferred with Buy, $30 target at H.C. Wainwright 11/08/20 Oppenheimer Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer FIXX Homology Medicines $7.24 / +0.07 (+0.98%) 03/11/21 Homology Medicines reports Q4 EPS (62c), consensus (68c) 11/09/20 Homology Medicines reports Q 3EPS (62c), consensus (80c) 07 Apr FIXX Homology Medicines $7.24 / +0.07 (+0.98%) 04/07/21 Fly Intel: Pre-market Movers 04/06/21 Fly Intel: After-Hours Movers 11/19/20 Fly Intel: After-Hours Movers 04/15/21 FuboTV
Conference/Events	Deere management to meet virtually with Oppenheimer » 14:57 04/14/21 04/14 14:57 04/14/21 14:57 DE Deere $381.47 / +2.69 (+0.71%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DE Deere $381.47 / +2.69 (+0.71%) 02/24/21 Deere board increases quarterly dividend 18% to 90c 02/19/21 Deere: Supplies of key components and parts remain tight 02/19/21 Deere committed to improving diversity at company 02/19/21 Deere: Large tractor order book now extends into Q4 DE Deere $381.47 / +2.69 (+0.71%) 04/13/21 Deutsche Bank Deere price target raised to $402 from $360 at Deutsche Bank 04/12/21 Wolfe Research Deere initiated with an Outperform at Wolfe Research 03/16/21 Citi Deere price target raised to $400 from $375 at Citi 03/04/21 Citi Deere price target raised to $375 from $325 at Citi DE Deere $381.47 / +2.69 (+0.71%) 02/19/21 Deere sees FY21 Production & Precision Agriculture revenue up 1% 02/19/21 Deere raises FY21 earnings outlook to $4.6B-$5B from $3.6B-$4B 02/19/21 Deere reports Q1 EPS $3.87, consensus $2.16 02/18/21 Notable companies reporting before tomorrow's open DE Deere $381.47 / +2.69 (+0.71%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/19/21 Fly Intel: Pre-market Movers 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 04/15/21 FuboTV 04/16/21 Deere DE Deere $381.47 / +2.69 (+0.71%) 02/19/21 Early notable gainers among liquid option names on February 19th

Events

Earnings calls, analyst events, roadshows and more

Today at 15:45

Federal Reserve’s New Policy Framework Government Event

Virtual Event
AFMD
Today at 16:05

Affimed - AFMD Conference Calls
BRFH
Today at 16:30

Barfresh Food Group - BRFH Conference Calls
Today at 18:05

Fed Reserve Bank President Participates in Virtual Event Government Event

Virtual Event
GHG
Today at 21:00

GreenTree Hospitality - GHG Conference Calls
AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
COO
Tomorrow at 00:00

Cooper Companies - COO Conference Calls
VNRX
Tomorrow at 00:00

VolitionRx - VNRX Conference Calls
VERI
Tomorrow at 00:00

Veritone - VERI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	DISCA X DISCA Discovery Block Trade Managers: Credit Suisse Priced at: $38.40 19M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $32.35 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IQ X IQ iQIYI Block Trade Managers: Credit Suisse Priced at: $15.85 35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham Priced at: $30.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $250 Reference Price 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Secondary Managers: SBHS $10.94 45M Shares
Fri	No deals

View All Syndicate Announcements »

Sientra reports Q2 EPS (68c), consensus (43c)

TODAY'S FREE FLY STORIES

Get Full Fly Access